Ratan Tata-backed startup Generic Aadhar launches pharmacy aggregator app
Pharmacy retail chain Generic Aadhar on Monday announced an app that will get generic medicines from nine pharmaceutical manufacturers and sell them at its outlets.
The chain, which is led by 18-year-old Arujun Deshpande and is backed by Tata Group chairman emeritus Ratan Tata, grew in 2020 by adding 450 franchise stores to take its total count to 650 odd stores in 100 cities.
Founded in 2019, the startup procures generic (unbranded) medicines from around nine major pharmaceutical manufacturers. These manufacturers, in Gujarat, Maharashtra, Pondicherry, are all World Health Organisation-Good Manufacturing Practices (WHO-GMP) certified.
Generic medicines use the same salt as a branded medicine, but their prices are 60-80 per cent lower.
Deshpane, founder and CEO of Generic Aadhar, said the company offers a 40 percent margin to the retailer and has a central warehouse from which the medicines are distributed across its stores throughout the country.
In 2021, the firm aims to take its store count to 2500. “We expect that through the app each store has a potential to generate an additional Rs 3 lakh per month business,” Deshpande says.
The app will aggregate the orders and the nearest Generic Aadhar store will deliver the medicines to the doorstep.
Tata, who was present at the launch, said that it was important to ensure that besides the affordable price, the medicines were also of optimum quality. “Otherwise it would be a great opportunity lost,” he said.
The veteran industrialist had invested an undisclosed amount in Generic Aadhar in May last year. He had earlier invested in another health care start-up called Lybrate, which helps connect patients with doctors.Tata has invested in over a dozen other start-ups such as Firstcry, Paytm and Snapdeal.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.